TRANSPUPILLARY THERMOTHERAPY OF THE OPTIC NERVE DISK IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION

Código QR

TRANSPUPILLARY THERMOTHERAPY OF THE OPTIC NERVE DISK IN THE TREATMENT OF CENTRAL RETINAL VEIN OCCLUSION

Purpose: to make a pathogenetic basis and assessment of the clinical efficacy of transpupillary thermotherapy (TTT) of the optic nerve disc in central retinal vein occlusion (CRVO). Materials and methods: ophthalmological examination with in-depth study of regional hemodynamics, layered structure of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	M. V. Akulenko, A. G. Shchuko, T. N. Iureva, V. V. Bukina
Formato:	article
Lenguaje:	RU
Publicado:	Scientific Сentre for Family Health and Human Reproduction Problems 2016
Materias:	occlusion of the central retinal vein transpupillary thermotherapy of the optic disc Science Q
Acceso en línea:	https://doaj.org/article/e978d4b31a4c4f8787d2f575078a90fd
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Characteristics of Somatic Status and Individual Biochemical Markers in Patients with Retinal Vein Occlusion
por: I. V. Zlobin, et al.
Publicado: (2019)

Central retinal vein occlusion and pseudoexfoliation syndrome
por: Karagiannis D, et al.
Publicado: (2015)

Dexamethasone implant in retinal vein occlusions
por: Han SB, et al.
Publicado: (2016)

Anti-VEGF treatment of macular edema associated with retinal vein occlusion: patterns of use and effectiveness in clinical practice (ECHO study report 2)
por: Jumper JM, et al.
Publicado: (2018)

Retinal vein occlusion with cerebral infarction in a preterm neonate: a case report
por: Xiuyu Zhu, et al.
Publicado: (2021)

Systemic abnormalities associated with retinal vein occlusion in young patients
por: Sinawat S, et al.
Publicado: (2017)

Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes
por: Dixon SG, et al.
Publicado: (2016)

Vitrectomy for macular edema due to retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
por: Ivanovska Adjievska B, et al.
Publicado: (2017)

Usefulness of anti-vascular endothelial growth factor combined with dexamethasone implant for retinal vein occlusion
por: Kim M
Publicado: (2016)

Impact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusion
por: Sivaprasad S, et al.
Publicado: (2016)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
por: Paulose R, et al.
Publicado: (2016)

Artificial intelligence can assist with diagnosing retinal vein occlusion
por: Qiong Chen, et al.
Publicado: (2021)

Hyperreflectivity of Inner Retinal Layers as a Quantitative Parameter of Ischemic Damage in Acute Retinal Vein Occlusion (RVO): An Optical Coherence Tomography Study
por: Furashova O, et al.
Publicado: (2020)

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy
por: Wallsh J, et al.
Publicado: (2016)

Anti-VEGF treatment and peripheral retinal nonperfusion in patients with central retinal vein occlusion
por: Abri Aghdam K, et al.
Publicado: (2017)

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion
por: Peng-Yao Lin, et al.
Publicado: (2021)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
por: Oellers P, et al.
Publicado: (2016)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
por: Singer MA, et al.
Publicado: (2016)

Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
por: Callizo J, et al.
Publicado: (2019)

Influence of sanatorium treatment with thermotherapy on the adaptive capacity of hard-working people
por: A. A. Fedotchenko, et al.
Publicado: (2016)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
por: Sakanishi Y, et al.
Publicado: (2017)

Morphologic Classifications and Locations of Microaneurysms and Clinical Relevance in Branch Retinal Vein Occlusion
por: Esaki Y, et al.
Publicado: (2020)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
por: Takeyama M, et al.
Publicado: (2017)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
por: Michalska-Małecka K, et al.
Publicado: (2016)

Prolongation of injection interval after switching therapy from ranibizumab to aflibercept in Japanese patients with macular edema secondary to branch retinal vein occlusion
por: Tagami M, et al.
Publicado: (2017)

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation
por: Kawamura M, et al.
Publicado: (2018)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
por: Saquib Naeem, et al.
Publicado: (2019)

Obstructive Sleep Apnea is Related with the Risk of Retinal Vein Occlusion
por: Wan W, et al.
Publicado: (2021)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
por: Dogan E, et al.
Publicado: (2018)

Five-year outcomes of pars plana vitrectomy for macular edema associated with branch retinal vein occlusion
por: Nishida A, et al.
Publicado: (2017)

Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis
por: Tufail A, et al.
Publicado: (2018)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
por: Kumagai K, et al.
Publicado: (2019)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
por: Tsai MJ, et al.
Publicado: (2018)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
por: Laine I, et al.
Publicado: (2017)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
por: Narayanan R, et al.
Publicado: (2016)

Optical coherence tomography parameters predictive of visual outcome after anti-VEGF therapy for retinal vein occlusion
por: Fujihara-Mino A, et al.
Publicado: (2016)

Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea
por: Kim MS, et al.
Publicado: (2021)

Efficacy of anti-VEGF therapy combined with iontophoresis of Xueshuantong injection on retinal vein obstruction with macular edema
por: Zi-Yue Xiang, et al.
Publicado: (2021)

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
por: Kartasasmita AS, et al.
Publicado: (2016)